ViroPharma to Release 2008 Third Quarter Financial Results on Octobe... (

ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008

Date:10/14/2008

- Conference Call to Discuss Results to Be Held at 9:00 A.M. -

EXTON, Pa., Oct. 14 /PRNewswire-FirstCall/ -- ViroPharma Incorporated's (Nasdaq: VPHM) third quarter financial results for 2008 are expected to be released on Wednesday, October 29, 2008 before the open of the U.S. financial markets.

The company will host a conference call and live audio webcast at 9:00 a.m. Eastern Time on the same day. During the conference call, ViroPharma management will discuss the third quarter financial results for 2008 and other business.

The press release and the live webcast of the conference call will be accessible via ViroPharma's corporate website at http://www.viropharma.com. An audio archive will be available at the same address until November 15, 2008. To participate in the conference call, please dial 877-366-0713 (domestic) and 302-607-2000 (international). After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. ViroPharma to Present at Three October Healthcare Conferences
2. ViroPharma to Present at Three September Healthcare Conferences
3. ViroPharma To Acquire Lev Pharmaceuticals
4. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
5. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
6. ViroPharma to Present at Two Upcoming Healthcare Conferences
7. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
8. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
9. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
10. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
11. ViroPharma to Present at the BIO CEO & Investor Conference

Post Your Comments:

(Date:12/11/2009)... Leuven, 10 December 2009 -- Researchers have discovered a new ... males. The more excess copies of a certain gene, the ... the X-chromosome; and it is suspected that it is the ... The results are being published in the American Journal ... by the group of Guy Froyen connected to VIB, a ...

(Date:12/11/2009)... -- Ambit Biosciences Corporation announced today the enrollment and ... Cancer Center of the first patient in the ACE ... fficacy) Phase 2 pivotal trial in patients with ... is a novel, orally available, potent and highly selective ... tyrosine kinase-3 (FLT3) inhibitor. The ACE study is ...

(Date:12/11/2009)... Marrone Bio Innovations (MBI) today announces ... Mr. Chris Hildreth joined MBI as Senior Vice ... expanding all commercial aspects of the company, including ... Sing (Ray) Lam joined MBI as Vice President ... efforts in scaling its broad pipeline of products ...

(Date:12/11/2009)... Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, ... announced the appointment of Dr. Alan Warrander to ... and Business Development. ,, "Dr. Warrander will be ... strategy for REOLYSIN(R)," said Dr. Brad Thompson, President ... on the design of a Phase 3 trial ...

Breaking Biology Technology:Amount of gene surplus determines severity of mental retardation in males 2 Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2 Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3 Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4 Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5 Marrone Bio Innovations Announces Two New Executive Appointments 2 Marrone Bio Innovations Announces Two New Executive Appointments 3 Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2 Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3

[0] Amount of gene surplus determines severity of mental retardation in males [0] Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia [0] Marrone Bio Innovations Announces Two New Executive Appointments [0] Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development

... Elbit Imaging Ltd.,(Nasdaq: EMITF ) ("EI" ... the,fiscal year 2007., Transition to IFRS, ... have been,prepared in accordance with generally accepted accounting ... the provisions of Standard 29 of the Israeli,Accounting ...

... Lowering the blood pressure of elderly patients could cut ... cardiovascular events by a third,according to a new study ... and published simultaneously in the New England,Journal of Medicine., ... in the,Very Elderly Trial (HYVET), which is co-ordinated by ...

... Revenue Increased 51.9% to $33.2 Million, ... Increased 49.3% to $12.8 Million, -- ... for 2008 NEW YORK and HAIKOU, Hainan, China, ... Bulletin Board: CPHI) which develops, manufactures, and,markets generic and ...

Elbit Imaging Ltd. Announces Results For Fiscal Year 2007 Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over China Pharma Holdings, Inc. Announces Record 2007 Year End Results

(Date:12/14/2009)... once thought of tool use as a defining feature of ... other primates, along with birds and an array of other ... Current Biology , a Cell Press publication, adds an ... veined octopus under study manages a behavioral trick that the ... itself over stacked, upright coconut shell "bowls," makes its eight ...

(Date:12/13/2009)... to engineer plants that take advantage of elevated carbon ... help to engineer crops that take advantage of rising ... they need for photosynthesis through microscopic breathing pores in ... the gas gained, they lose hundreds of water molecules ... save water when CO 2 is abundant, but ...

(Date:12/13/2009)... 10, 2009Researchers at The Scripps Research Institute have ... protein from an ancient family of enzymes can ... In addition to providing guidance for understanding other ... theoretical underpinning for the protein,s possible use for ... The research was published in the December 13, ...

Breaking Biology News(10 mins):Tool use in an invertebrate: The coconut-carrying octopus 2 Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2 Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3 Scripps Research scientists crack mystery of protein's dual function 2 Scripps Research scientists crack mystery of protein's dual function 3 Research team finds first evolutionary branching for bilateral animals 10060 1 Research team finds first evolutionary branching for bilateral animals 10060 2 Habits May Keep Couples Together or Tear Them Apart 58147 1 Habits May Keep Couples Together or Tear Them Apart 58147 2 Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics 28TCT 29 Meeting 58143 1 Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics 28TCT 29 Meeting 58143 2

[0] Tool use in an invertebrate: The coconut-carrying octopus [0] Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops [0] Scripps Research scientists crack mystery of protein's dual function

... Health have developed an experimental vaccine that could, theoretically, ... malaria parasite from an area's mosquitoes. , The ... the immune system of a person who receives it ... a malaria-carrying mosquito, after the mosquito has fed upon ...

... apprehensive of new experiences as infants maintain that temperament ... do their more adventuresome sisters, according to new research ... , The apprehensive rats were more likely to have ... could account for hormonal differences linked to the development ...

... shape may predict the survival of corals around the world ... come, according to a new model that relies on engineering ... climate change, as well as future tsunamis, will have major ... week in the international scientific journal Nature. Shape and size ...

Other Biology News:Malaria vaccine prompts victims' immune system to eliminate parasite from mosquitoes 2 Malaria vaccine prompts victims' immune system to eliminate parasite from mosquitoes 3 Temperament linked to onset of cancer and early death in female rats 2 Coral reefs are increasingly vulnerable to angry oceans 2 Coral reefs are increasingly vulnerable to angry oceans 3

Malaria vaccine prompts victims' immune system to eliminate parasite from mosquitoes Temperament linked to onset of cancer and early death in female rats Coral reefs are increasingly vulnerable to angry oceans

ANTI S. ENTERID LPS...

B.D. Hames and D.M. Glover (1996) • This issue covers T-Cell antigen receptor genes; T-Lymphocyte signal transduction; B-Cell activation antibody engineering and the complement system and other ...

Request Info...

RABBIT ANTI PORCINE CARBOXYPEPTIDASE B...

Biology Products:

Mouse Anti-SALMONELLA ENTERIDITIS (LPS GPD; 0-9 AG) Monoclonal Antibody, Unconjugated, Clone D:8HG from AbD Serotec Molecular Immunology from Promega Feline IL-4 ELISA development Kit, DuoSet Economy Pack from R&D Systems Rabbit Anti-Porcine CARBOXYPEPTIDASE B Polyclonal Antibody, Unconjugated from AbD Serotec

ViroPharma to Release 2008 Third Quarter Financial Results on Octobe...( - Conference Call to Discuss R...)